Disclosures: Consulting Fee-Current-Boston Scientific Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-ECG Consultants I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Medtronic, Inc.,Receipt of Intellectual Property Rights/Patent Holder-current-Left atrial appendage occluder LLC,Consulting Fee-current-Sorin Biomedica Cardio S.R.L.,Consulting Fee-current-AtriCure, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Bayer Healthcare Pharmaceuticals, Cell Medica, AstraZeneca, Autolus, Seattle Genetics, Genentech/Roche, Gilead, Takeda,Research Support-current-Genentech/Roche, Seattle Genetics, Regeneron, Infinity, Millenium, Janssen Pharmaceutical, Bristol Myers Squibb, Pharmacyclics, Kura, Merck, Agensys, Celgene, Forty Seven Inc, Teva Pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Boehringer Ingelheim Vetmedica GmbH I/we have no financial relationships to report. Speakers Bureau-Current-Bristol-Myers Squib Aventis,Consulting Fee-Current-Eli Lilly and Company I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-MT Pharma America,Speakers Bureau-Akcea,Consulting Fee-Biohaven,Speakers Bureau-current-Alnylam pharmaceuticals,Consulting Fee-ALNYLAM,Consulting Fee-Biogen Idec I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Boston Scientific Corporation,Consulting Fee-Current-Toray Industries, Inc.,Speakers Bureau-Current-Medtronic, Inc.,Speakers Bureau-Current-Abbott Vascular,Speakers Bureau-current-Johnson and Johnson I/we have no financial relationships to report. Consulting Fee-Current-Pulse Biosciences I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-current-St. Jude Medical, Inc.,Contracted Research-Current-Abbott Laboratories,Contracted Research-Current-Roche,Consulting Fee-Current-Roche I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-7/1/2018-Biomarin I/we have no financial relationships to report. Consulting Fee-Current-Medtronic, Inc.,Contracted Research-Current-DEXCOM,Contracted Research-current-Novo Nordisk,Contracted Research-current-Astra-Zeneca,Consulting Fee-Advisory Board Member-Current-Novo Nordisk, Inc,Consulting Fee-Current-Dexcom, Inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-Current-Springer Publications/Demos Medical Publishing I/we have no financial relationships to report. advisory board participation-9/29/2017-Astellas,flight to Israel for a meeting for a trial that I am US PI-flight retutn was 6/6/18 but I continue to be US PI on trial-BioSight I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-current -Reshape ,Consulting Fee-date ended June 2012-Applied Medical ,Receipt of Intellectual Property Rights/Patent Holder-current -Gusto LLC Consulting Fee-Current-Inomed Ownership Interest-Current-Chimu Solutions LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-ended-Merck and Company, Inc.,Research support-Current-Ferring I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Abbott Laboratories,Speakers Bureau-Current-Novartis AG,Consulting Fee-Current-GE Healthcare Bio-Sciences Investigator Initiated Research-Current-Medtronic, Inc.,Honoraria (Speaker fees)-Medtronic, Inc.,Investigator Initiated Research-Current-Baylis Medical I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Allergan I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-may 2018-navigant consulting I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Biodesix,faculty for educational activities-Current-CHEST,Advisory board-Current-Olympus,Advisory Board-Current-Boston Scientific Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Data Monitoring Committee Member-current-AstraZeneca,Advisory Board\Consultant\Research Grant-current-Eli Lilly and Company,Data Safety Monitoring Board\Advisory Board-Current-Boehringer Ingelheim Vetmedica GmbH,Contracted Research-Advisory Board\Research Grant-current-Novo Nordisk Consulting Fee-Scientific advisor-Advanced Radiation Therapy, inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-Eisai, Inc.,Speakers Bureau-current-UCB Pharma I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I am the Assistant Editor-in-Chief of Anesthesiology, The Journal of the American Society of Anesthesiologists, Inc. Northwestern University receives salary support from the American Society of Anesthesiologists for this position and I receive an hororarium from them. -Ongoing.-American Society of Anesthesiologists I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-W. L. Gore and Associates, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I was awarded a Fellow Scholar grant to support my research through Stanley Manne Children’s Research Institute and Ann & Robert H. Lurie Children’s Hospital of Chicago-Current I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Merck and Company, Inc.,Contracted Research-Vascular Dynamics,Contracted Research-Bayer Corporation,Contracted Research-Johnson and Johnson I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-current-American Psychiatric Publishing, Inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Novartis AG,Consulting Fee-current-Pfizer, Inc.,Consulting Fee-current-Merck and Company, Inc.,Consulting Fee-current-Genentech/Roche,Consulting Fee-current-Sanofi-Aventis,Consulting Fee-current-Taiho,Consulting Fee-current-Radius Health,Consulting Fee-Current-Immunomedics,Consulting Fee-Current-Spectrum Pharma,Consulting Fee-current-Daiichi Sankyo Consulting Fee-current-Johnson and Johnson I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. speaking honorarium Roche -current I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Gift to support my research at NU-Current-Simulab I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-Mead Johnson Nutrition I/we have no financial relationships to report. Consulting Fee-Current-J&J Vision-They have no bearing on the educational content planned/presented. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-Current-Medacta I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-current-La Jolla Pharmaceuticals,Salary-current-Astellas,Consulting Fee-current-Boston Biomedical Receipt of Intellectual Property Rights/Patent Holder-Current-SpIntellx (new startup company) I/we have no financial relationships to report. Receipt of Intellectual Property Rights/Patent Holder-current-Boston University,Royalty-current-Boston University,Royalty-current-UpToDate, Inc.,Contracted Research-08/21/2018-Sanofi-Genzyme,Contracted Research-10/31/2018-Pfizer CTI,Advisory Board-current-Genentech, Inc.,I gave an uncompensated webinar that was hosted by Euroimmun describing the scientific and clinical evidence that would support their diagnostic test-09/25/2018-Euroimmun US I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-TEVA,Speakers Bureau-current-Neurocrine,Speakers Bureau-current-Adamas,Speakers Bureau-current-Acorda Therapeutics I/we have no financial relationships to report. Consulting Fee-ended Nov 2018-Bayer Corporation,Consulting Fee-ended Nov 2018-Thermofisher scientific ,Speakers Bureau-ended January of 2018 -American society of clinical pathology sponsored by Bristol Mayer I/we have no financial relationships to report. Salary-Current-Lundbeck I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Stock-Penumbra, Xablecath, Scientia, Brightwater,Consulting Fee-W. L. Gore and Associates, Inc.,Consulting Fee-Penumbra, Cordis (Cardinal), Scientia, Argon Medical I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Endo Pharma,Consulting Fee-Current-Coloplast I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-AtriCure, Inc.,Consulting Fee-current-Allergan INc.,Consulting Fee-current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-West Pharma Ownership Interest-Current-SketchyMedical online meded course (not directly healthcare related) I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting and Speakers Bureau-Current-Abbott Vascular,Consulting Fee-Current-Amgen,Consutling and Speakers Bureau-Current-Boehrginer Ingelheim Pharma Inc.,Consulting Fee-Current-Medtronic,Consulting Fee-Current-Bristol Myers Squibb,Consulting Fee-Current-Oruen, Inc.,Consulting Fee-Current-WebMD,Consulting Fee-Current-Hospital Quality Foundation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-Editor-in-chief, Current Problems in Diagnostic Radiology, Elsevier Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-Boehringer Ingelheim Vetmedica GmbH,Speakers Bureau-current-Genentech, Inc. I/we have no financial relationships to report. Consulting Fee-Current-Green Thumb Industries I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Sanofi-Aventis I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Magellean I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-AtriCure, Inc.,Speakers Bureau-Current-Sorin Biomedica Cardio S.R.L.,Consulting Fee-Current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-current-Philips Medical Systems, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Allakos, Inc.,Ownership Interest-Current-Allakos, Inc.,Receipt of Intellectual Property Rights/Patent Holder-Current-Johns Hopkins University,Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-Current-UpToDate and Elsevier editorial royalties I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Receipt of Intellectual Property Rights/Patent Holder-Current-Boston Scientific Corporation-Millipede, Pipeline I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-current-Merck and Company, Inc.,Contracted Research-current-Roche,Contracted Research-current-Wockhardt,Contracted Research-current-Shionogi,Contracted Research-Entasis Pharma,Contracted Research-current-Allecra Therapeutics,Contracted Research-current-Achaogen I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-current-Agile MD, RxRevu I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-current-Lundbeck,Consulting Fee-Current-Third Rock Ventures I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consultant or Speaker or Advisor -All current -Salix, Ironwood, Allergan, Synergy, Shionogi, Astra Zeneca, Daiichi Sankyo, Medtronic, Shire Pharmaceuticals, Medscape LLC, Alphasigma USA, US WorldMeds, and the GI Health Foundation and PriMed LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Co-chair of trial steering committee, formerly medical advisory board (all compensation paid to Columbia University)-Current-ALung Technologies received fee for proctoring with EVAR device-current-Endologix, Inc. I/we have no financial relationships to report. Consulting Fee-Current-Richard Wolf Endoscopes I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-Molecular Solutions Development Company,SBIR Co-investigator-Current-Deoxylytics LLC,Contracted Research-Current-Amway,Current I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-6/17, 12/16 & 12/16-Sage Therapeutics, Janssen & Gerson Lehrman Group-Provided consultation regarding perinatal depression in general I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Edwards Lifesciences LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-Current-Innomed I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Receipt of Intellectual Property Rights/Patent Holder-current-Medtronic, Inc.,Consulting Fee-current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-ended November 2017-Bayer Corporation,Contracted Research-current-Bayer Corporation,Speakers Bureau-current-Guerbet,Contracted Research-current-Guerbet,Consulting Fee-current-GE Healthcare Bio-Sciences,Consulting Fee-current; no money received-Siemens AG,Consulting Fee-ended Nov 2017-circle I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-AtriCure, Inc.,Consulting Fee-current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Genentech, Inc.,Consulting Fee-AstraZeneca,Consulting Fee-Guardant Health,Consulting Fee-Foundation Medicine,Consulting Fee-Biodesix I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-ended 7/29/2018-Menlo Therapuetics,Consulting Fee-2/16/2018-Intraderm Pharmaceuticals I/we have no financial relationships to report. Consulting Fee-Current-Alcon,Consulting Fee-Current-Allergan,Consulting Fee-Current-Bausch and Lomb,Consulting Fee-Current-Visunex I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-Bristol-Myers Squibb,Advisory Board-ended-EMD Serono I/we have no financial relationships to report. Consulting Fee-10/5/18-Alnylam,Consulting Fee-11/10/18-Arena,Consulting Fee-6/1/18-Salix,Consulting Fee-10/10/18-Synergy,Speakers Bureau-04/28/18-Allergan,Consulting Fee-10/11/18-Im HealthSciences,Consulting Fee-Current-Ironwood,Consulting Fee-10/9/18-Ritter,Contracted Research-10/8/18-Ardelyx I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Alexion Pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Receipt of Intellectual Property Rights/Patent Holder-Patent-Current-None,Contracted Research-Ended > 2 years ago-Mallinckrodt, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Endo Pharmaceuticals I/we have no financial relationships to report. Speakers Bureau-Current-Stryker Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting and/or honoraria-Boehringer Ingelheim-Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, Abbvie, Janssen, Bayer and Prometic ,Operational funding for clinical trials-Boehringer Ingelheim-Lilly, Merck, Janssen, Sanofi and AstraZeneca I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-Current-Neon Therapeutics,Advisory Board Member-Ended 11/15/18-Cota Healthcare I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Johnson and Johnson I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-current-Bayer Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-8/31/2018-Castle Biosciences I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Abbott Laboratories,Consulting Fee-current-Aptinyx,Advisory, Strategic, Scientific or Medical Board-current-Astellas Pharmaceutical,Consulting Fee-current-Cerephex,Consulting Fee-current-Daiichi Sankyo,Consulting Fee-current-Pfizer, Inc.,Speakers Bureau-current-Pierre Fabre,Consulting Fee-current-Samumed,Consulting Fee-current-Theravance,Consulting Fee-current-Tonix,Advisory, Strategic, Scientific or Medical Board-Zynerba I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Takeda Pharmaceuticals, Inc.,Ownership Interest-Current-RenalytixAI,Consulting Fee-Current-CHF Solutions,Consulting Fee-8/1/18-pulseData,Consulting Fee-Current-Quark Biopharma,Consulting Fee-12/17-Johnson and Johnson I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-Medical Error Reduction Ceritfication, Inc (MERCI) I/we have no financial relationships to report. Research funding-Current-SAGE, Sunovion, and more-None I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-within past 12 months-Novartis AG,Consulting Fee-May 2017-Mylan I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-current-United Shockwave Therapies I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-10/2017-keyquest health,Consulting Fee-10/2017-cota,Consulting Fee-2/15/18-loxo oncol,clinical research support-current-threshhold,Contracted Research-current-AstraZeneca,Contracted Research-current-innate,Contracted Research-current-Bristol-Myers Squibb,Contracted Research-current-cellsight,Contracted Research-current-tessa I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Johnson and Johnson I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Intersect ENT,Consulting Fee-current-Xoran I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-Current-Advanced Respiratory Technologies,Gift-Current-Alung I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Castle Biosciences, Inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-Attune Medical I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consultant, SAB, Stockholder-current-AtriCure, Inc.,Board of Directors-Current-PAVmed, Inc.,Salary-Current-Northwestern University,Consultant, BOD, Stockholder-Current-Adagio Medical,Stockholder, Consultant-Current-SentreHEART and Clearflow Inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Pfizer, Inc.,Consulting Fee-Current-Novartis AG,Consulting Fee-Current-CytoDyn,Consulting Fee-Current-Merus,Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-Current-Pfizer, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Indivior I/we have no financial relationships to report. Consulting Fee-Current-Quentis Therapeutics, Inc. Consulting Fee-Current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Spouse-GlaxoSmithKline I/we have no financial relationships to report. Contracted Research-Ended June 2018-Theratechnologies I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Gilead,Speakers Bureau-Current-Gilead,Consulting Fee-Current-United Therapeutics,Speakers Bureau-Current-United Therapeutics,Consulting Fee-current-Actelion,Speakers Bureau-Current-Actelion,Contracted Research-current-Actelion,Contracted Research-current-Reatta Pharmaceuticals,Contracted Research-Current-United Therapeutics,Consulting Fee-current-Bayer Corporation,Speakers Bureau-Bayer Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-5/2017-Baxter International, Inc.-Unrelated Consulting Fee-Current-Stryker, Spinal Elements I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Medtronic, Inc.,Speakers Bureau-current-Edwards Lifesciences LLC,Speakers Bureau-current-AtriCure, Inc.,Speakers Bureau-current-atricure,research grant-current-Atricure I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-current-Monteris Contracted Research-Current-Edwards Lifesciences LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Curret-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-AstraZeneca,Speakers Bureau-Current-Novo Nordisk,Contracted Research-current-Boehringer-Ingelheim, Astra Zeneca, Janssen, Merck,Advisory Board-current-Astra Zeneca, Novo Nordisk, Janssen, Boehringer-Ingelheim, Intarcia, Elcelyx I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Boston Scientific Corporation,Consulting Fee-Abbott Vascular,Consulting Fee-Abiomed, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Novartis AG,Consulting Fee-Current-Abbott Laboratories,Consulting Fee-Current-AstraZeneca,Consulting Fee-Current-DalCor Pharma,Consulting Fee-Current-Relypsa,Consulting Fee-Current-Boston Scientific Corporation,Consulting Fee-Current-Signature Medical,Contracted Research-Current-Novartis AG I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Spectranetics Corporation,Consulting Fee-Current-Cook Group Incorporated,Speakers Bureau-Current-AngioDynamics, Inc.,Speakers Bureau-Current-Boston Scientific Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Biomerix Coporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Cordis Corporation,Speakers Bureau-current-W. L. Gore and Associates, Inc.,Contracted Research- current-Acelity I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-ArborMetrix I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Equity Ownership-Current-Magenta Therapeutics,Consulting Fee-Current-Amphivena Therapeutics,Consulting Fee-Current-Celgene,Consulting Fee-Current-Incyte,Consulting Fee-Current-Karyopharm Therapeutics,Consulting Fee-Current-RiverVest Venture Partners,Consulting Fee-Current-Tioma Therapeutics,Membership on a Board or Advisory Committee-Current-Cellworks Group, Inc,Membership on a Board or Advisory Committee-Current-RiverVest Venture Partners,Contracted Research-Current-Amphivena Therapeutics,Contracted Research-Current-Novimmune I/we have no financial relationships to report. Contracted Research-Current-Celgene-I am talking about immunology and they are an immunotherapy company,Contracted Research-Current-EMD Serono-I am talking about immunology and they manufacture immunotherapeutics ***Also-I hold patents on cancer vaccines through the University of Washington and I may talk about cancer vaccines,Contracted Research-Current-Pfizer, Inc.,Contracted Research-Current-Epithany,Contracted Research-Current-Janssen,Contracted Research-July 2018-Silverback Therapeutics,Ownership Interest-Current-Epithany I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-Dock Health,Ownership Interest-Current-Health Voyager,Consulting Fee-Current-TigerConnect,Ownership Interest-current-uBiome I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-6/2018-AstraZeneca,Consulting Fee-6/2018-Bristol-Myers Squibb I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-artegraft I/we have no financial relationships to report. I/we have no financial relationships to report. clinical trial funding (no personal payments)-current-Spark Therapeutics I/we have no financial relationships to report. Ownership Interest-Current-Compugen, Harpoon, Kleo, Tizona,Consulting Fee-Current-Agenus, Dendreon, Janssen, Lilly, Merck, Medimmune, Pierre Fabre, Roche/Genentech,Royalty-Current-BMS, Astrazeneca, Medimmune, Janssen Consulting Fee-current-GlaxoSmithKline,Consulting and contracted clinical trials -12/31/2018-Pulmonx,Consulting Fee-12/31/2018-AstraZeneca,Consulting Fee-12/31/2018-PneumRx/BTG,Consulting Fee-12/31/2018-Quark I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-Gilead I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-Current-Up to Date,Investigator initiated grant-current-Merck and Company, Inc.,Contracted Research-current-HRA Pharma,Ad Board-Current-Agile I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Receipt of Intellectual Property Rights/Patent Holder-current-Nanostring/Prosigna,Consulting Fee-2017-Novartis AG,Consulting Fee-2017-Pfizer, Inc.,Consulting Fee-2018-ABBVIE,Consulting Fee-2017-Puma,Consulting Fee-2017-AstraZeneca,Consulting Fee-2018-Zeno Consulting Fee-Current-Abbott Laboratories,Consulting Fee-Current-Boston Scientific Corporation,Contracted Research-Current-Medtronic, Inc.,Contracted Research-Current-Boehringer Ingelheim Vetmedica GmbH I/we have no financial relationships to report. Consulting Fee-Current-Zimmer Biomet I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-W. L. Gore and Associates, Inc.,Consulting Fee-Bard Peripheral Vascular, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Gore I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Celgene Corporation Pediatric Advisor I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Abbott Vascular,Contracted Research-Current-Medtronic, Inc.,Contracted Research-Current-CathWorks,Consulting Fee-Current-Boston Scientific Corporation,Stock Options-Current-HeartFlow I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Investigator-initiated research grant-Current-Bristol-Myers Squibb,Investigator-initiated research grant-Current-Pfizer, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-BTG,Consulting Fee-current-B&D,Speakers Bureau-current-Cook Group Incorporated,Consulting Fee-current-Terumo Cardiovascular Systems Group,Consulting Fee-current-W. L. Gore and Associates, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Merck and Company, Inc.,Consulting Fee-Current-Abbvie,Contracted Research-Current-Abbvie,Contracted Research-Gilead,Consulting Fee-Gilead,Consulting Fee-Intercept,Consulting Fee-Salix,Consulting Fee-Dova Speakers Bureau-current-Novartis AG I/we have no financial relationships to report. Consulting Fee-Current-BD I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Medtronic, Inc.,Consulting Fee-current-Johnson and Johnson,Royalty-current-Merck and Company, Inc.,Consulting Fee-Current-Avra,Salary-Current-Sangamo Biologics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Coverage of travel costs for consulting, where payment for consulting goes to my institution rather than me-Current-Johnson and Johnson,Coverage of travel costs for consulting; the consulting fee goes to my institution-Current-United Therapeutics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-McKesson Health Solutions I/we have no financial relationships to report. I/we have no financial relationships to report. Salary, Research funding-Current-Sage Therapuetics, JDS, Mass General Hospitial-No relation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Hologic Speakers Bureau-current-Sanofi-Aventis,Speakers Bureau-current-Novartis AG,Contracted Research-current-Shire,Ownership Interest-current-Transplant Genomics, Inc.,Contracted Research-current-Transplant Genomics, Inc.,Consulting Fee-Dec 2017-Abbvie,Contracted Research-Current-Vitaeris,Contracted Research-Current-Abbvie I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Research funding-Current-Gilead I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Gilead I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-I am AtriCure's Medical Director-AtriCure, Inc. I/we have no financial relationships to report. Consulting Fee-Allergan,Consulting Fee-Alcon I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Active-Amgen, Inc.-There is no relationship Consultant-Current-Castle Biosciences,Consultant-Current-Merck and Company, Inc.,Consultant-Current-Myriad Genomics,Consultant-Current-DermTech Int. Research- Site PI-12/2018-Sunovion I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Medtronic, Inc.,Consulting Fee-Current-Longeviti, LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Johnson and Johnson,Contracted Research-Current-Angel Medical Systems, Inc.,Contracted Research-Current-CSL Behring,Consulting Fee-Current-Janssen,Consulting Fee-Current-Portola Pharmaceuticals, Inc.,Consulting Fee-Current-Arena Pharmaceuticals,Consulting Fee-Current-Amarin,Consulting Fee-Amgen,Consulting Fee-Current-Boehringer Ingelheim Vetmedica GmbH,Consulting Fee-Current-Bayer Corporation,Consulting Fee-current -Chiesi,Ownership Interest-Current - Wife is owner-Boston Clinical Research Institute,Consulting Fee-Current-Merck and Company, Inc.,Consulting Fee-Current-Cardiovascular Research Foundation,Consulting Fee-Current-Eli Lilly and Company,Consulting Fee-Current-Gilead,Consulting Fee-Current-Impact Bio,Consulting Fee-Current-The Medicines Company,Consulting Fee-Current-MedImmune,Consulting Fee-Current-Medtelligence,Consulting Fee-Current-Novo Nordisk,Consulting Fee-Current-Pfizer, Inc.,Consulting Fee-Current-Sanofi-Aventis,Consulting Fee-Current-Somhlution,Consulting Fee-Current-St. Francis Hospital,Consulting Fee-Current-Vereseon Corp,Consulting Fee-Current-WEbMD,CEO-Current-Baim Institute I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Boston Scientific Corporation-Auris Robotics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted trainer, periodically contracted as independent contractor-Current-Metaphrasis Language and Cultural Services I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Equity, Board of Directors - Non Executive-Current-GlaxoSmithKline,Ownership Interest-July 21, 2017-Bristol-Myers Squibb,Founder, Equity, and Chair of SAB-Current-Quentis Therapeutics,Equity, Board of Directors-Current-Waters Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Advisory board--funds to Mayo Clinic -current-Lilly,Advisory board--funds to Mayo Clinic-current-Biovica,Advisory board--funds to Mayo Clinic-current-Novartis,Advisory board--funds to Mayo Clinic-current-Sermonix,Advisory board--funds to Mayo Clinic-current-Context Pharmaceuticals,Advisory board--funds to self-current-Genomic Health,Research funds-current-Lilly,Research funds-current-Pfizer I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Acadia,Consulting Fee-11/18-Aptinyx,Consulting Fee-Current-Sunovion,Consulting Fee-Current-Worldwide Med,Salary-11/30/18-Rush University Medical Center,Salary-Current-Shirley Ryan Abilitylab,Grants/research from Acadia, CHDI, Consolidated Anti-Aging, NIH, Michael J. Fox Foundation, Parkinson's Foundation-11/18,Grants/research from Michael J. Fox Foundation, Parkinson's Foundation-Current,Honoraria from American Academy of Neurology, International Parkinson's Disease and Movement Disorders Society, Parkinson's Foundation-Current I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-AbbVie,Speakers Bureau-Current-Coloplast,Contracted Research-Current-Marius,Consulting Fee-Current-Mitsubishi Tanabe,Contracted Research-Current-Plethora,Contracted Research-Current-Tissue Genesis,Consulting Fee-Current-AMAG Pharmaceuticals,Speakers Bureau-current-AMAG Pharmaceuticals,Investigator Initiated Research Grant-Current-AMAG Pharmaceuticals,Investigator Initiated Research Grant-current-BTL Industries,Speakers Bureau-Current-Elen (Deka),Contracted Research-Current-Endoceutics,Consulting Fee-Current-Ipsen,Contracted Research-Current-Ipsen,Consulting Fee-Current-Strategic Science & Technologies,Contracted Research-Current-Strategic Science & Technologies,Consulting Fee-Current-Sprout honoraria/consulting fees/in-kind compensation; membership on an advisory panel-Current-AbbVie Pharmaceutical, Inc.,Membership on an advisory panel-Current-Allergan, Plc,Membership on an advisory panel-Current-Bausch & Lomb,Recipient of grants/research supports; Participation in clinical trial; Membership on an advisory panel-Current-Clearside Biomedical, Inc.,Participation in clinical trial-Current-pSivida Corp.,Consulting fees; advisor-Current-Santen Pharmaceutical Co., Ltd. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Novartis AG I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Abbott Vascular,Contracted Research-Current-Medtronic, Inc.,Contracted Research-Current-Edwards Lifesciences LLC,Contracted Research-Current-Neochord I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Johnson and Johnson Consulting Fee-current-Allergy Therapeutics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-Current-Baxter International, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-DBV, Aimmune Therapeutics, Before Brands, Genentech, Pfizer, Kaleo, Inc. ,Contracted Research-Current-National Institutes of Health, Stanford University, Aimmune Therapeutics, United Health Group, d National Confectioners Association, Thermo Fisher, Rho, Inc,Food Allergy Research & Education - unpaid advisor Allergy and Asthma Network - speaker -Current I/we have no financial relationships to report. Research funding and Honorarium-Current and ended 4/2017-Sage Pharmaceuticals and Abbott Nutrition-Neither are related to the content I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Pacira Pharmaceuticals,Contracted Research-Current-BioQ Pharma,Contracted Research-Current-Haylard Health,Contracted Research-2016-Trevena Inc,Consulting Fee-Current-Trevena Inc,Consulting Fee-October 2018-Health Decisions,Speakers Bureau-Current-Acacia Pharma I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current -Bristol-Myers Squibb,Consulting Fee-current -Merck and Company, Inc.,Consulting Fee-current-Genentech, Inc.,Consulting Fee-CURRENT-Pfizer, Inc.,Consulting Fee-CURRENT-LOXO,Consulting Fee-CURRENT-Eisai, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-active -R.L. Gore,Consulting Fee-Current -Medtronic, Inc. I/we have no financial relationships to report. Speakers Bureau-Current-Abbott Vascular,Speakers Bureau-Current-Baylis Medical,Speakers Bureau-currrent-Boston Scientific Corporation,Speakers Bureau-Current-Edwards Lifesciences LLC,Speakers Bureau-Current-Siemens AG,Consulting Fee-Current-Medtronic, Inc.,Consulting Fee-Current-Philips Medical Systems, Inc.,Consulting Fee-Current-Siemens AG I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Affera,Consulting Fee-Current-Johnson and Johnson,Consulting Fee-Current-Boston Scientific Corporation,Consulting Fee-12/1/2018-Cryofix,Consulting Fee-Current-Integer,Consulting Fee-Current-Luxcath,Consulting Fee-Current-Medtronic, Inc.,Consulting Fee-Current-Philips Medical Systems, Inc.,Consulting Fee-Current-VerAFeye I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Advisory board member-ended 12/1/2017-Bristol-Myers Squibb I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consultant, speaker, clinical research-Current-Abbvie,Consultant, clinical research-Current-Allergan,Consulting Fee-Current-Amgen,Consulting Fee-Current-Boehringer Ingelheim Vetmedica GmbH,Consultant, clinical research-Current-Celgene,Consulting Fee-Current-Celltrion,Consultant, clinical research-Current-Genentech, Inc.,Consultant, clinical research-Current-Gilead,Consulting Fee-Current-Hospira,Consultant, speaker, clinical research-Current-Janssen,Consulting Fee-Current-Merck and Company, Inc.,Consultant, speaker, clinical research-Current-Pfizer, Inc.,Consulting Fee-Current-Salix,Consulting Fee-Current-Shire,Consultant, speaker, clinical research-Current-Takeda Pharmaceuticals, Inc.,Consulting Fee-Current-UCB I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-current-Hologic Inc,Ownership Interest-current-Volpara LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-CVS I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Boston Scientific Corporation,Consulting Fee-Current-Medtronic, Inc.,Consulting Fee-Current-Olympus I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Research-current-Orion-not mentioned as part of educational content,Consulting Fee-current-Bristol-Myers Squibb-not part of educational content I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-ended 12/31/17-Siemens AG I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Abbott Laboratories,Consulting Fee-Boston Scientific Corporation,Consulting Fee-Medtronic Core Valve,Consulting Fee-Edwards Lifesciences LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Novartis AG Consulting Fee-current-Google I/we have no financial relationships to report. Royalty-Current - chapter author.-UpToDate I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Boston Scientific Corporation-Boston Scientific,Consulting Fee-12/31/18-Biogen Idec-Biogen I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-Current-Baxter International, Inc. Consulting Fee-Current-Novartis AG,Contracted Research-Current-Astellas Pharma I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. My husband's business runs lab tests using Quest diagnostic services. My husband pays Quest diagnostic to run the lab tests. -current-Quest diagnostics Consulting Fee-Current-Boston Scientific Corporation,Consulting Fee-Current-Nexthera I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Variant,Consulting Fee-Current-Dimerix,Royalty-Current-Up To Date I/we have no financial relationships to report. Consulting Fee-Current-Medtronic, Inc.,Speakers Bureau-Current-Medtronic, Inc.,Consulting Fee-Current-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Founder and Scientific Advisor-Current-Surgical Vision Technologies, Inc. I/we have no financial relationships to report. Receipt of Intellectual Property Rights/Patent Holder-current-AbbVie,Consulting Fee-current-Genentech, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-current-Abbvie I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Pfizer, Inc.,Consulting Fee-current-Global Blood Therapeutics,Contracted Research-current-Pfizer, Inc.,Contracted Research-current-Global Blood Therapeutics,Contracted Research-2018-AstraZeneca,Consulting Fee-2018-AstraZeneca,Consulting Fee-current-HPC Hilton Publishing ,Consulting Fee-2018-Emmi Solutions,Contracted Research-current-Ironwood,Contracted Research-current-Imara,Data Safety and Monitoring Board-current-University of Cincinnati,Consulting Fee-current-Emmaus,Consulting Fee-current-Investment analysts - with Gerson Lehman Group, Navigant, Guidepoint, Slingshot, System Analytics Royalty-current-Stryker,Speakers Bureau-current-Medtronic, Inc.,Consulting Fee-current-wright medical,Speakers Bureau-current-bioventus,Speakers Bureau-current-minus,Consulting Fee-current-nuvasive I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Receipt of Intellectual Property Rights/Patent Holder-Current-Edwards Lifesciences LLC,Consulting Fee-Current-Edwards Lifesciences LLC,Consulting Fee-Current-Abbott Vascular,Consulting Fee-Current-Medtronic, Inc. Research funding-current-Eisai, Inc.,review EEG data for phase 1 clinical trials-current-Sage Medical, Inc.,Advisory board-current-Eisai, Inc. Salary-Current -Elsevier (Journal Editor) I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Content Author-Current-Up-To-Date I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Baxter International, Inc.,Consulting Fee-current-Cook Group Incorporated,Consulting Fee-current-Boston Scientific Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Johnson and Johnson Consulting Fee-ended-AstraZeneca,Contracted Research-Current-AstraZeneca,Contracted Research-current-Bayer Corporation,Contracted Research-Current-Genentech, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Active-AstraZeneca,Consulting Fee-Active-Pfizer, Inc.,Research Support-Tesaro Consulting Fee-Current-Bayer Corporation,funding for research-Current-Shire I/we have no financial relationships to report. Royalty-Current-UpToDate,Consulting Fee-Current-Shionogi I/we have no financial relationships to report. Consulting Fee-Current-CVS/Caremark I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-Embolitech,Consulting Fee-Current-Philips Medical Systems, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-ended 12/2017-Merck and Company, Inc.,Consulting Fee-CPT Advisor for AASM, current -American Academy of Sleep Medicine I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Co-founder -Ended January 2018- Acquired by Celgene-Impact Biomedicines Inc,Co-founder-Current-Wintherix Inc,Patent Royalties-Current-Forty Seven Inc,Unrestricted Research grant-Current-Johnson and Johnson,Unrestricted Research grant-Current-Celgene 12/31/2017 I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Bay Labs, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-10/1/18-Gilead,Contracted Research-5/1/18-Alios,Contracted Research-10/1/18-Abbvie,Contracted Research-9/1/18-Merck and Company, Inc.,Consulting Fee-current-AstraZeneca I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Ended 11/18-GE Healthcare Bio-Sciences I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Array Biopharma,Consulting Fee-Current-Bristol-Myers Squibb,Consulting Fee-Current-Incyte,Consulting Fee-Current-Novartis AG,Consulting Fee-Current-Merck and Company, Inc. I/we have no financial relationships to report. Advisory Board Member-Current-Bio K+ International; CutisPharma; Acurx Pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Institutional research support for DEFINE-FLOW (NCT02328820)-Current-Philips Medical Systems, Inc.,Institutional licensing and consulting for smart minimum FFR algorithm-Current-Boston Scientific Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-Pacylex, Inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Ironwood,Consulting Fee-Current-Reckitt Benckiser I/we have no financial relationships to report. Speakers Bureau-Eisai, Inc.,Speakers Bureau-PUMA,Speakers Bureau-Novartis AG,Speakers Bureau-celgene,Speakers Bureau-Genentech, Inc.,Consulting Fee-Pfizer, Inc.,Consulting Fee-celldex,Consulting Fee-AstraZeneca,Consulting Fee-amgen,Consulting Fee-athenex,Speakers Bureau-Pfizer, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Ended 5/31/2018-GlaxoSmithKline,Consulting Fee-Ended - April 2018-CVS Caremark,Consulting Fee-Ended - January 2018-Boston Scientific Corporation,Research Grant Support (to NU)-Ended - March 2018-GlaxoSmithKline,Research Grant Support (to NU)-Current-BTG/PneumRx,Research Grant Support (to NU)-Current-Spiration Consulting Fee-Current-CME Outfitters, LLC,Consulting Fee-Current-Pritzker Neuropsychiatric Disorders Research Consortium, LLC,Consulting Fee-Current-Skyland Trail Advisory Board,Consulting Fee-Current-TC MSO, Inc., Actify Neurotherapies,Consulting Fee-Current-American Psychiatric Association, American Journal of Psychiatry,Payment for Journal Editor-Elsevier, Scientific Journal Publisher I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Medtronic, Inc.,Contracted Research-Current-Medtronic, Inc.,Contracted Research-Ablative Solutions I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Abbott Vascular,Consulting Fee-current-Boston Scientific Corporation,Stock options-current-Valcare I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Advisory Board, Consultant-Amgen,Contracted Research-Current-Intracellular Therapies Inc.,Advisory Board-Current-Cytokinetics,Consulting Fee-Current-Janssen,Contracted Research-Current-Boehringer Ingelheim Vetmedica GmbH,Scientific Advisory Board-Current-Cardurion Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Xellia,Consulting Fee-current-Achaogen,Consulting Fee-current-Merck and Company, Inc.,Contracted Research-cirremt-Merck and Company, Inc.,Consulting Fee-current-Shinogi,Consulting Fee-current-Zavante,Consulting Fee-current-Melinta,Consulting Fee-current-Paratek,Consulting Fee-current-Nabriva,Consulting Fee-current-allergan Royalty-current-Novartis AG,Royalty-current-Xenon Pharmaceuticals,Royalty-current-Stoke Therapeutics,Royalty-current-Encoded Genomics,Royalty-current-Life Splice Pharma,Consulting Fee-current-Encoded Genomics,Consulting Fee-current-Praxis Precision Medicines,Sponsored Research-current-National Institutes of Health,Contracted Research-current-Ovid Pharmacueticals I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-Quest Diagnostics Consulting Fee-4/28/2018-Novartis AG,Contracted Research-current-Promet Pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Received an honorarium for attending a meeting on speaker training for the medication Truvada, but declined to participate in a Speaker's Bureau-4/20/18-Gilead I/we have no financial relationships to report. Consulting Fee-ended 2/26/18-Intraderm pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-480 Biomedical ,Consulting Fee-Sanofi-Aventis,Consulting Fee-Astella,Consulting Fee-NUIG I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Boston Scientific Corporation,Consulting Fee-Current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Recipent of Medical Education Grant -Ended: November 2017-Shire (formerly Baxalta),Recipent of research grant funding (NIAID grant sub-contract)-Current-National Institutes of Health,Recipent of research grant funding -Ended: July 2017-Becton-Dickinson Biosciences I/we have no financial relationships to report. Consulting Fee-current-Boston Scientific Corporation,Consulting Fee-current -Olympus I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Abbvie,Consulting Fee-Current-Olympus,Consulting Fee-Current-Applied Medical Ownership Interest-Current-Health Data Link, Inc.,Consulting Fee-Current-Tempus LLC,Consulting Fee-2018-Regeneron I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Johnson and Johnson,Consulting Fee-Bayer Corporation,Consulting Fee-Pfizer, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-AtriCure, Inc.,Consulting Fee-Current-St. Jude Medical, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-CVS Caremark I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-November 2018-Boston Scientific Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Research support-Current-Sage Therapeutics-I will be mentioning my work on the PPIU including possibly mentioning the RCT of the IV Brexananione for which the PPIU was site I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. honorarium-current-Genomic Health I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I am Director of the non-commercial Data Center for STS-INTERMACS and receive support through funds paid to my institution (UAB).-Current-STS-INTERMACS I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Abbott Laboratories,Contracted Research-Current-NHLBI,Ownership Interest-Current-ReThink Medical,Ownership Interest-Current-Signature Medical,Consulting Fee-Current-Signature Medical,Consulting Fee-Current-Endotronix,Consulting Fee-Current-Medtronic, Inc.,Consulting Fee-Current-Boston Scientific Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-St. Jude Medical, Inc.,Consulting Fee-current-Boston Scientific Corporation,Consulting Fee-current-Medtronic, Inc.,Consulting Fee-current-Biotronik, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-More Health, Inc,Board member-Current-Alliance Family of Companies I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Checkpoint Surgical, Inc.,Scientific Advisory Board-Current-Mesh Suture, Inc. I/we have no financial relationships to report. Consulting Fee-current-Synthetic Biologics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Nanovis I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Boston Scientific Corporation,Consulting Fee-current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-current-Abbott Laboratories I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-AstraZeneca,Contracted Research-current-Boehringer Ingelheim Vetmedica GmbH,Consulting Fee-current-AstraZeneca,Consulting Fee-current-Boehringer Ingelheim Vetmedica GmbH,Consulting Fee-current-Sanofi-Aventis,Consulting Fee-current-GlaxoSmithKline,Consulting Fee-current-Amgen,Consulting Fee-current-Novo Nordisk,Consulting Fee-current-Merck and Company, Inc.,Consulting Fee-current-Eisai, Inc.,Consulting Fee-current-Glytec,Consulting Fee-current-Janssen,Consulting Fee-current-Intarcia,Consulting Fee-current-Novartis AG,Consulting Fee-current-Bayer Corporation,Consulting Fee-current-Applied Therapeutics I/we have no financial relationships to report. Consulting fee, Ownership interest, Royalty-current-Nuvasive,Consultant, potential for future royalty-current-Medtronic, Inc.,Royalty-current-Spinewave I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fees and Contracted Research -Current -Astute Medical -bioMérieux,Contracted Research-June 2018 -Satellite Healthcare ,Consulting Fee-Current -Sphingotec I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Travel Reimbursement-December 2017-Vizient I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-AstraZeneca I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Bayer Corporation,Consulting Fee-Bristol-Myers Squibb,Consulting Fee-Eisai, Inc.,speaker at CME-BTG I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Abbvie,Consulting Fee-Current-Angiochem I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Novo Nordisk,Consulting Fee-current-Retrofit,Consulting Fee-current-Weight Watchers I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Abbvie,Consulting Fee-Current-Ferring,Contracted Research-Current-La Jolla,DSMB, consulting, shareholder-Durect ,Consulting Fee-Current-Johnson and Johnson,Contracted Research-Current-Allergan,Consulting Fee-Current-Dova,Contracted Research-Current-Assembly Biosciences,Consulting Fee-Current-Shionogi,Consulting and Fees for non-CE services-Current-Merck and Company, Inc.,Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-Consulting and Contracted Research-Current-Gilead Consulting Fee-January 2019-Bristol-Myers Squibb,Royalty-Current-Uptodate,Contracted Research-November 2018-Roche,Consulting Fee-current-American College of Cardiology I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-AtriCure, Inc. I/we have no financial relationships to report. Consulting Fee-Current-Novartis AG,Consulting Fee-Current-Janssen Pharmaceutica Products LP,Consulting Fee-Current-Abbvie, Inc. ,Consulting Fee-Current-Threshold,Consulting Fee-Current-Lindi,Consulting Fee-Current-EMD Serono,Consulting Fee-Current-Bristol-Myers Squibb,Consulting Fee-Current-Genentech, Inc.,Consulting Fee-Current-Galderma,Consulting Fee-Current-Debiopharm,Consulting Fee-Pfizer, Inc.,Consulting Fee-Helsinn Healthcare SA ,Consulting Fee-Silf Therapeutics,Consulting Fee-GSK,Consulting Fee-Foamix,Consulting Fee-Boehringer Ingelheim Vetmedica GmbH,Consulting Fee-Medische Voet,Consulting Fee-Legacy,Consulting Fee-Johnson and Johnson,Consulting Fee-Merck and Company, Inc.,Consulting Fee-Novocure,Consulting Fee-E.R. Squibb & Sons, L.L.C. ,Consulting Fee-Amgen Inc.,Consulting Fee-Seattle Genetics,Consulting Fee-Bayer Corporation,Consulting Fee-Manner SAS,Consulting Fee-Menlo Therapeutics,Consulting Fee-Lutris,Consulting Fee-Llloyd's Bank,Consulting Fee-Paxman,Consulting Fee-Adgero,Royalty-Berg,Royalty-Bristol-Myers Squibb,Royalty-Genentech, Inc.,Royalty-RJR Fund,Royalty-Paxman,Royalty-Veloce,Royalty-US Biotest,Royalty-Novartis AG I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Vertex Pharmaceuticals,Consulting Fee-Current-Gilead I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Scientific Advisory Board -Current -Applied Therapeutics I/we have no financial relationships to report. Consulting Fee-Current-Biogen Idec I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Dicerna Pharmaceuticals, Inc.,Consulting Fee-Current-Horizon Pharmaceuticals, Inc.,Consulting Fee-Current-Janssen Pharmaceuticals, Inc.,Consulting Fee-Current-Eli Lilly and Company,Consulting Fee-Current-Alexion Pharmaceuticals, Inc.,Editor-in-Chief, Pediatric Nephrology Text-Current-MedScape I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-SentreHEART,Ownership Interest-Life Signals, Inc,Ownership Interest-Woodside Medical I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-current-Cook Group Incorporated,Contracted Research-current-W. L. Gore and Associates, Inc.,Contracted Research-current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. Invited Speaker - Payment for services and travel reimbursement-8/10/2017-Prevention Genetics,Invited Speaker at conference - conference registration waived-2/1/2017-Genetic Task Force of Illinois I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-AstraZeneca,Speakers Bureau-Johnson and Johnson I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-Gilead,Speakers Bureau-current-Novartis AG,Contracted Research-current-Novartis AG,Speakers Bureau-current-valeant I/we have no financial relationships to report. Contracted Research-Current-Novartis AG,Clinical Endpoint Committee - CHAMPION Post Approval Study-Current-St. Jude Medical, Inc.,Clinical Endpoint Committee - SOLVE-CRT-Current-EBR Systems Inc,Consulting Fee-Current-Impulse Dynamics Inc,Steering Committee - ADMIRE ICD - trial has been terminated-Current-GE Healthcare Bio-Sciences,Steering Committee Member for Remede Post Approval Registry-Current-Respircardia,University of Washington CoMotion owns the copyright to the Seattle Heart Failure Model and Seattle Proportional Risk Model-Current-N/A - University of Washington,Consulting Fee-Current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Research Support-current-Novartis AG I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Genentech, Inc.,Consulting Fee-current-Ophthea,Consulting Fee-Current-Santen,Consulting Fee-current-pSivida,Consulting Fee-Current-Kodiak,Speakers Bureau-current-Genentech, Inc.,Consulting Fee-Current-Quark,Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-Current-Alcon,Royalty-CRC Press I/we have no financial relationships to report. Research support in the form of contributed product-current-Stryker Corporation,Research support in the form of contributed product-Current-OpGen, Inc.,Investigator-initiated grant-Ended-CareFusion Foundation (now part of BD) I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Medtronic, Inc.,Consulting Fee-Current-Medtronic, Inc.,Consulting Fee-Current-Boston Scientific Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current (Investigator-initiated research grant)-Ekos Corporation,Contracted Research-Current (investigator-initiated research grant)-GE Lifesciences I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Ended Feb 2018-Guerbet I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current, Array Biopharma-Array,Contracted Research-current, OncoSec-OncoSec,Contracted Research-current-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-consultant-Circassia Pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-current-GlaxoSmithKline I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Abbvie,Consulting Fee-Current-NewLink Genetics,Consulting Fee-Current-ReNeuron,Honoraria for medical editing-Current-Medlink Neurology,Honoraria for medical editing-Current-EBSCO,Honoraria for presenting CME Board Review lectures-Current-American Physician Institute I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-4/29/17-Syndex,Consulting Fee-7/22/2017-Eli Lilly and Company,Consulting Fee-12/6/2017-Tempus,Consulting Fee-12/7/2017-Pfizer, Inc.,Contracted Research-Current-Pfizer, Inc.,Contracted Research-Ongoing-Puma Biotechnology,Contracted Research-current-Eisai I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Medical Advisory Board-Current-Boston Scientific Corporation Speakers Bureau-Current-LivaNova,Contracted Research-Current-LivaNova,Contracted Research-Current-UCBPharma,Speakers Bureau-Current-UCBPharma,Speakers Bureau-Current-Sunovion I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Genentech, Inc.,Consulting Fee-Current-EMD Serono,Consulting Fee-Current-Bristol-Myers Squibb,Speakers Bureau-Amgen Inc,Speakers Bureau-Eisai, Inc.,Contracted Research-Merck and Company, Inc.,Consulting Fee-Bayer Corporation,Speakers Bureau-Exelixis,Contracted Research-Oncolytics I/we have no financial relationships to report. Speakers Bureau-current-Boehringer Ingelheim Vetmedica GmbH,Speakers Bureau-Circassia,Speakers Bureau-Mylan,Speakers Bureau-Stallergenes/Greer,Speakers Bureau-Kaleo I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Abbott Vascular,Speakers Bureau-Current-Edwards Lifesciences LLC,Consulting Fee-Current-Cryolife,Consulting Fee-Current-Edwards Lifesciences LLC,Advisor-Current-Edwards Lifesciences LLC,Contracted Research-Current-Edwards Lifesciences LLC,Contracted Research-Current-Vascutek,Contracted Research-Current-Cryolife I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Recipient of the Society of Vascular Surgery Seed Grant “VasoVasorum Volume and Stroke Prediction”-Current,Proctor to train surgeons on how to perform safe TCAR -Current-Silk Road Medical,Contracted Research-Current-CRESTI, CRESTII, CREST Companion Study, ROADSTERI, ROADSTERII, ROADSTER Long-Term Follow up Study, SAPHIRE I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-12/2018-Pfizer, Inc.,Speakers Bureau-12/2018-Bristol-Myers Squibb,Consulting Fee-Current-Superior Ambulance,Consulting Fee-current-chicago blackhawks organization,Consulting Fee-Current-US Soccer Federation,Legal consulting -Current-Donahue Brown I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Verrica,Consulting Fee-Ended July 2018-Pfizer, Inc.,Consulting Fee-Ended July 2018-Pampers,Consulting Fee-Ended July 2018-Pierre Fabre Speakers Bureau-Current-AbbVie,Speakers Bureau-current-Genentech, Inc.,Speakers Bureau-current-Lilly,Speakers Bureau-current-Pfizer, Inc.,Speakers Bureau-current-Sanofi/Genzyme - Regeneron,Speakers Bureau-current-UCB,Consulting Fee-current-CVS I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Abbott Laboratories,Consulting Fee-Johnson and Johnson,Consulting Fee-Medtronic, Inc.,Consulting Fee-Boston Scientific Corporation,Consulting Fee-Philips Medical Systems, Inc.,Contracted Research-Pfizer, Inc.,Contracted Research-Boehringer Ingelheim Vetmedica GmbH,Contracted Research-ACT,Consulting Fee-EPD,Ownership Interest-NewPace I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. honorarium for speaking-3GEN I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Circle Cardiovascular Imaging I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-11/10/2018-AstraZeneca,Consulting Fee-7/20/2018-Genentech, Inc.,Consulting Fee-Tesaro I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-AstraZeneca,Consulting Fee-Genentech, Inc.,Consulting Fee-Eli Lilly and Company,Consulting Fee-Novartis AG,Consulting Fee-Macrogenics,Consulting Fee-Seattle Genetics,Consulting Fee-Immunomedics,Contracted Research-Genentech, Inc.,Contracted Research-Pfizer, Inc.,Contracted Research-Novartis AG I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Sage Medical, Inc.,Royalty-current-Wolters Kluwer Publishing,Contracted Research-current-Merck and Company, Inc.,Contracted Research-current-MECTA Corp.,Speakers Bureau-current-CME Outfitters I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Edwards Lifesciences LLC,Royalty-Current-Edwards Lifesciences LLC,Consulting Fee-Current-Medtronic, Inc.,Advisory Board-Current-Abbott Vascular,honorarium-Current-AtriCure, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Husband works for GI supply, Marketing-Current-GI Supply I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Invitae,Consulting Fee-ended-Fibrogen,Consulting Fee-current-AstraZeneca,Consulting Fee-current-Exonics,Consulting Fee-ended-Pfizer, Inc. Consulting Fee-Current-Abbott Vascular I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-AstraZeneca,Consulting Fee-Janssen,Consulting Fee-ColdGenesys,Consulting Fee-Ferring I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current -Abbott Laboratories,Consulting Fee-Current -CardioKinetix Inc.,Consulting Fee-Current -Spectranetics Corporation,Consulting Fee-Current -Boston Scientific Corporation,Consulting Fee-Current -Cardiovascular Systems, Inc,Consultant (spouse)-Current -Abiomed, Inc.,Research Funding to the Institution -Current -AstraZeneca,Resarch Funding to the Institution -Current -Bayer Corporation,Advisory Board Funding to the Institution -Current -Bristol-Myers Squibb,Research Funding to the Institution -Current -Beth Israel Deaconess I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Celgene Grant funding-Current-Sage Medical, Inc.-I will be presenting one talk on the data from a published clinical trial funded by Sage Therapeutics and will give full disclosure. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Founder-Central Line Health, LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Active-Novartis AG,Contracted Research-Active-AstraZeneca,Contracted Research-Active-Genentech, Inc.,Contracted Research-Active-Daiichi Sankyo,Contracted Research-Active-Taiho Pharmaceutical,Contracted Research-Active-Calithera Biosciences,Contracted Research-Active-Bayer Corporation,Contracted Research-Active-Aileron Therapeutics,Contracted Research-Active-PUMA Biotechnology,Contracted Research-Active-CytoMx Therapeutics,Contracted Research-Active-Zymeworks,Contracted Research-Active-Curis,Contracted Research-Active-Pfizer, Inc.,Contracted Research-Active-eFFECTOR Therapeutics,Contracted Research-Abbvie,Active-Debiopharm Group,Contracted Research-Active-Guardant Health,Consulting Fee-Ending 12/31/2018-Genentech, Inc.,Consulting Fee-Ended 6/5/2018-Inflection Biosciences,Consulting Fee-Ending 12/1/2019-Samsung Bioepis,Consulting Fee-Ended 6/1/2018-Aduro,Consulting Fee-Ended 6/2/2018-Spectrum,Consulting Fee-Ending 5/31/2019-OrigiMed,Consulting Fee-Ending 2/19/2021-Debiopharm Group,Consulting Fee-Ending 12/31/2010-Xencor,Consulting Fee-Ending 12/31/2018-Jackson Laboratory,Employee-Current-UT-MD Anderson Cancer Center Consulting Fee-Current-AbbVie,Consulting Fee-Current-AstraZeneca,Both Consulting Fees and Research Support-Current-Boehringer Ingelheim Vetmedica GmbH,Both Consulting Fees and Research Support-Current-Bristol-Myers Squibb,Both Consulting Fees and Research Support-Current-Celgene,Both Consulting Fees and Research Support-Current-ChemoCentryx,Both Consulting Fees and Research Support-Current-Genentech, Inc.,Consulting Fee-Current-Sanofi-Aventis,Both Consulting Fees and Research Support-Current-GlaxoSmithKline,Both Consulting Fees and Research Support-Current-InflaRx,Consulting Fee-Current-Insmed,Consulting Fee-Current-Janssen,Consulting Fee-Current-Kiniksa,Research support-Current-Kypha,Research support-TerumaBCT,Royalty-Current-UpToDate I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I receive compensation from Northwestern University as an Independent Contractor for my position as Vice Chairman IRB Panel C.-Current I/we have no financial relationships to report. Royalty-Current-UpToDate,Consulting Fee-current-UCB,Consulting Fee-current-Esai,Consulting Fee-Current-Xenon,Speakers Bureau-Current-Mallinkrodt,Speakers Bureau-Current-Sunovion Royalty-current-Elsevier Publishing Compnay I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-W. L. Gore and Associates, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Boston Scientific Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Cormatrix,Shareholder-Current-Cormatrix I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-AstraZeneca,Consulting Fee-current-Astellas ,Consulting Fee-current-Sanofi-Aventis,Consulting Fee-current-Bayer Corporation,Consulting Fee-current-Janssen I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Archeus Technologies Ltd.,Receipt of Intellectual Property Rights/Patent Holder-Current-Wisconsin Alumni Research Foundation I/we have no financial relationships to report. I/we have no financial relationships to report. Dr. Monica Morrow has received speaking honoraria from Roche and Genomic Health-current-Dr. Monica Morrow has received speaking honoraria from Roche and Genomic Health-No relation to presentation. Part of a topic requested by multiple attendees at last years meeting. Salary-Current-Sage Therapeutics-The treatment may be mentioned but it is not a primary topic of the panel. I/we have no financial relationships to report. Consulting Fee-current-Pfizer, Inc.,Consulting Fee-current-Novartis AG,Consulting Fee-current-Takeda Pharmaceuticals, Inc.,Consulting Fee-current-Regeneron,Consulting Fee-current-Myokardia,Contracted Research-current-Bristol-Myers Squibb,Contracted Research-current-Pfizer, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Boston Scientific Corporation,Speakers Bureau-AbbVie I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Co-investigator on research grant-current (07/12/2017-07/11/2018)-Paratek Pharmaceuticals,Co-investigator on research grant-ended (04/07/2015-01/01/2018)-Merck and Company, Inc.,Co-investigator on research grant-current (04/07/2015-04/01/2018)-Merck and Company, Inc.,Co-investigator on research grant-ended (03/01/2015-02/28/2017)-Forest / Astellas Royalty-Current-World Golf Foundation & European Tour-I will be discussing a product which is still investigational or not labeled for the use under discussion. This is not a conflict of interest and will not impact course delivery. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Medical Education Speakers Network. Book royalties Consulting Fee-Current-Leiters I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Honorarium -Current -Retrophin ,Contracted Research-Current -Allena I/we have no financial relationships to report. Contracted Research-current-Abbott Laboratories,Ownership Interest-current-NitroBiomedical LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Athenex,Consulting Fee-Daiichi Sankyo,Consulting Fee-Genentech, Inc.,Consulting Fee-Macrogenics,Consulting Fee and Contracted Research-Merck and Company, Inc.,DSMB member-G1 Therapeutics,Contracted Research-Celgene,Contracted Research-Corcept Therapeutics I/we have no financial relationships to report. I/we have no financial relationships to report. Receipt of Intellectual Property Rights/Patent Holder-current-Stanford University,Receipt of Intellectual Property Rights/Patent Holder-ended 07/31/2014-University of California Regents,Consulting Fee-current-Abbott Laboratories,Consulting Fee-current-Beyond Limits, AI,Consulting Fee-current-TDK, Inc,Consulting Fee-Current-American College of Cardiology,Royalty-Current-Uptodate I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting fee and honoraria-Current-Boston Scientific Corporation,Consulting fee and honoraria-Current-Abbott,consulting fee and honoraria-current-Medtronic, Inc.,Consulting fee and honoraria-currnet-Biosense Webster Consulting Fee-Abiomed, Inc.,Consulting Fee-AstraZeneca,Consulting Fee-Johnson and Johnson,Consulting Fee-Medtronic, Inc.,Consulting Fee-MAQUET GmbH and Co. KG,Consulting Fee-Merit Medical,Consulting Fee-Terumo Cardiovascular Systems Group Consulting Fee-Current-Xention,Consulting Fee-Current-Merck and Company, Inc.,Contracted Research-Current-OMEICOS Therapeutics,Receipt of Intellectual Property Rights/Patent Holder-Current-Institut de cardiologie de Montréal Consulting Fee-current-Sanofi, Regeneron, Amgen, Amarin, NovoNordisk, AstraZeneca,Contracted Research-current-Sanofi, Regeneron, Amgen, Janssen, Amarin I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-November 2018 ended-AstraZeneca Consulting Fee-current-Braun Medical, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Non paid consulting fee-Edwards Lifesciences LLC,non paid consulting fee-Medtronic, Inc.,non paid consultant-National Lung, Heart, and Blood Institute I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Advisory Board honorarium-ended-Gilead I/we have no financial relationships to report. Consulting Fee-Advisor, once within past 12 months-Novartis AG,Consulting Fee-Advisor, current-Eli Lilly and Company,Consulting Fee-Advisor, ongoing-Pfizer, Inc.,Consulting Fee-Advisor, one in past 12 months-PUMA,Consulting Fee-Advisor, one in past 12 months-Genentech, Inc.,Consulting Fee-Advisor, current -Macrogenics,Consulting Fee-Advisor, once in last 12 months-Immunomedics,Consulting Fee-Advisor, twice in last 12 months-Genomic Health I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Current I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-Current-Saunders Elsevier I/we have no financial relationships to report. I/we have no financial relationships to report. Serve on data committee-Current-Eli Lilly and Company I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Proteon Therapeutics,Consulting Fee-Current-Merck and Company, Inc.,Consulting Fee-Current-Medtronic, Inc. Consulting Fee-Current-Gladius Pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Abbvie,Consulting Fee-Actavis,Consulting Fee-Akcea,Consulting Fee-AstraZeneca,Consulting Fee-Amgen,Consulting Fee-Bayer Corporation,Consulting Fee-Boehringer Ingelheim,Consulting Fee-Cardiorentis,Consulting Fee-Daiichi Sankyo,Consulting Fee-Gilead,Consulting Fee-Johnson and Johnson,Consulting Fee-Novonordisk,Consulting Fee-Pfizer, Inc.,Consulting Fee-Relypsa,Consulting Fee-Sanofi-Aventis,Consulting Fee-Theravance Consulting Fee-current-Abbott Laboratories,Consulting Fee-current-Aperture Diagnostics,Consulting Fee-Current-Biosense Webster, Inc.,Consulting Fee-current-Biotronik, Inc.,Consulting Fee-current-Boston Scientific Corporation,Consulting Fee-current-CardioFocus,Consulting Fee-current-Johnson and Johnson,Consulting Fee-current-MediaSphere Medical,Consulting Fee-current-Medtronic,Consulting Fee-current-Siemens,Consulting Fee-current-St. Jude Medical, Inc.,Consulting Fee-current-SigNum Preemptive Healthcare, Inc.,Consulting Fee-Current-Spectrum Dynamics,Consulting Fee-current-Thermedical, Inc.,Contracted Research-current-Abbott Laboratories,Contracted Research-current-Biosense Webster, Inc.,Contracted Research-current-Boston Scientific Corporation,Contracted Research-current-CardioFocus,Contracted Research-current-Medtronic, Inc.,Contracted Research-current-Endosense,Contracted Research-current-Hansen Medical, Inc.,Contracted Research-current-NIH,Contracted Research-current-Robertson Foundation,Contracted Research-current-St. Jude Medical, Inc.,Contracted Research-current-Siemens,Contracted Research-current-Thermedical,Royalty-current-St. Jude Medical, Inc.,Royalty-current-Wiley and Sons,Royalty-current-Oxford I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-CUrrent-Gilead,Speakers Bureau-Current-Johnson and Johnson,Speakers Bureau-CUrrent-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Cofounder-Bold Diagnostics Speakers Bureau-current-Medtronic, Inc.,Royalty-Medtronic, Inc.,Speakers Bureau-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Clinical Drug Trial with Stealth Pharmaceutical. Study drug will be discussed I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-Current-UpToDate,Speakers Bureau-Current-Medtronic, Inc.,Contracted Research-Current-Pfizer, Inc.,Contracted Research-Current-AliveCor/Kardia,Contracted Research-Current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Honorarium-Current-Human Diagnosis Project I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Research grant not related to a pharmaceutical product-current-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Abbott Vascular I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-current-Pfizer, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-current President-Mustique Medical Ventures I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-On going-Cidara, Scynexis, Amplyx, Matinas, Astellas,Contracted Research-Cidara, Scynexis, Amplyx, Matinas, Astellas,Receipt of Intellectual Property Rights/Patent Holder-Rutgers University I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Omron Healthcare Co. LTD. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-Current-Elsevier Publishing Consulting Fee-Current-Philips Medical Systems, Inc. Consulting Fee-Sanofi-Aventis Consulting Fee-Current-Boston Scientific Corporation,Consulting Fee-11/15/2017-Johnson and Johnson I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Medtronic, Inc.,Consulting Fee-Abiomed, Inc.,Consulting Fee-CardiaAssist, Inc.,Consulting Fee-Thoratec I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Boston Scientific Corporation,Consulting Fee-current-Abbott Laboratories,Consulting Fee-current-Nevro,Consulting Fee-current-Jazz Pharmaceuticals,Contracted Research-current-Medtronic, Inc.,Contracted Research-current-Boston Scientific Corporation,Contracted Research-current-Abbott Laboratories,Contracted Research-current-Nevro,Contracted Research-current-Jazz Pharmaceuticals,Contracted Research-current-National Institutes of Health,Contracted Research-current-GE Global Research,Stock equity-current-AIM Medical Robotics,Medical Advisor-current-AIM Medical Robotics,Stock equity-current-Karuna Labs,Medical Advisor-current-Karuna Labs,Stock equity-ended Nov 2018-Centauri ,Medical Advisor-ended Nov 2018-Centauri I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-DBV Technologies I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-partial ownership; makes RPE cells for Lab use; we submitted a patent on RPE on fibrin but have not heard back-Lagen Laboratories I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Alnylam ,Consulting Fee-Current-Pfizer, Inc.,Consulting Fee-Current-Novartis AG,Ownership Interest-Current-Staten Biotechnology,Ownership Interest-Current-VascularStrategies I/we have no financial relationships to report. Consulting Fee-Consultant-Aptinyx Inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. receive travel reimbursement for committee meetings from American Academy of Pediatrics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-EriraRx,Ownership Interest-Current-GaudiumRx,Ownership Interest-Current-C-Diagnostics,Research Sponsor-Current-Bayer Corporation,Speakers Bureau-Current-Pfizer, Inc.,Speakers Bureau-Current-Astellas,Consultant-Current-Janseen I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-current-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Immucor, Inc. Consulting Fee-AstraZeneca,Consulting Fee-GlaxoSmithKline,Consulting Fee-Seattle Genetics,Contracted Research-Exagen I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-Advanced Medical Predictive Devices, Diagnostics and Displays I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-Cuurent-American Psychological Association I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ad Hoc Member of Scientific Advisory Board-Genentech, Inc.,Member of Scientific Advisory Board-Current-Belgian Volition,Consulting Fee-Current-Goldman Sachs,Member of Scientific Advisory Board-Current-Paige.AI,Ad Hoc Member of Scientific Advisory Board-Invicro,Ad Hoc Member of Scientific Advisory Board-Current-Roche,Ad Hoc Member of Scientific Advisory Board-Grail I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-CURRENT-Aries Pharmaceutical,Consulting, research support-CURRENT-Boston Scientific Corporation,research support-CURRENT-Colonary Solution,research support-CURRENT-Covidien,research support-CURRENT-EndoAid Ltd,consultant, research support-CURRENT-Olympus,Research Support-Current-paion,research support-current-braintree ,research support-Current-sebela I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Beaver-Visitec, Inc.,Speakers Bureau-Current-Bausch and Lomb I/we have no financial relationships to report. Speakers Bureau-current-Abbott Vascular,Speakers Bureau-current-Boston Scientific Corporation,Speakers Bureau-current-Abiomed, Inc. Consulting Fee-current-Tenax, Inc. Consulting Fee-Medtronic, Inc.,Speakers Bureau-Novartis AG I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Intercept pharmaceuticals,Consulting Fee-current-Gilead,Consulting Fee-current-Novartis AG,Consulting Fee-current-Nusirt Biopharma,Consulting Fee-current-NGM bio,Consulting Fee-current-enanta,Consulting Fee-current-Pfizer, Inc.,Consulting Fee-current-Genfit,Consulting Fee-current-Madrigal,Consulting Fee-current-Echosens I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-Spouse - Current-GN Hearing,Grant Subcontract - Site PI-Current-Wearafi, Inc. Salary-Current-Gatorade Sports Science Institute -None I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Varian,Grant to institution-Current-Varian Contracted Research-current - Acasti, Amarin, Amgen, Astra-Zeneca, Esai, Esperion, Merck, Novo-Nordisk, Pfizer, Regeneron, Sanofi, Takeda,Consulting Fee-current - Amgen, Merck, Novo-Nordisk, Pfizer, Regeneron, Sanofi-Novartis AG I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-CURRENT-PENTAX MEDICAL AND BOSTON SCIENTIFIC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-AstraZeneca,Consulting Fee-Current-Pfizer, Inc.,Advisory board, uncompensated-Current-Merck and Company, Inc.,Consulting Fee-McKesson,Contracted Research-Current-AstraZeneca,Contracted Research-Current-AbbVie,Contracted Research-Ended (within 3 years)-Biomarin,Contracted Research-Ended (within 3 years)-Tesaro,Contracted Research-Ended-Medivation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Abbott Laboratories,Consulting Fee-current-W. L. Gore and Associates, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-Sibel, Inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-Merck and Company, Inc.,Speakers Bureau-ended-Guardanthealth,research grant -ended-OncoDNA I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Optovue,Consulting Fee-Current-Boehringer Ingelheim Vetmedica GmbH,Consulting Fee-Current-Astellas,Receipt of Intellectual Property Rights/Patent Holder-Current-Opticology,Consulting Fee-Current-NanoRetina,Contracted Research-Current-Genentech, Inc.,Medical Advisory Board-Current-CellView,Consulting Fee-Current-Regeneron,Consulting Fee-Current-Diopsys,Stock Options-Current-Guardion Health I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-current-Boehringer Ingelheim Vetmedica GmbH,Contracted Research-current-AstraZeneca I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Boston Scientific Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-9/7/2018-Pfizer, Inc.,One time speaker fee February 2018. -2/28/2018-Paxman Scalp Cooling Systems I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Alcon I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-AbbVie,Consulting Fee-Current-Amgen,Consulting Fee-Current-Novartis AG,Consulting Fee-Current-Lilly Pharmaceuticals,Consulting Fee-Current-Janssen,Consulting Fee-Current-Pfizer, Inc.,Consulting Fee-Current-Sandoz,Consulting Fee-GlaxoSmithKline I/we have no financial relationships to report. Contracted Research-Current-Daiichi Sankyo,Contracted Research-Current-Pfizer, Inc.,Contracted Research-Current-Novartis AG,Contracted Research-Current-Merck and Company, Inc.,Contracted Research-Current-Lilly,Contracted Research-Current-OBI Pharma,Contracted Research-Current-Odonate,Contracted Research-Current-Genentech, Inc.,Contracted Research-Current-Eisai,Contracted Research-Current -Macrogenics,Contracted Research-Current-Seattle Genetics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Boehringer Ingelheim,Contracted Research-Current-Bardy Dx,Contracted Research-Current-Boston Scientific Corporation,Contracted Research-Current-Medtronic, Inc.,Steering Committee (Research Study) - not accepting honoraria-Current-Boston Scientific Corporation,Steering Committee (Apple Heart Study) - not accepting honorarium-Current-Apple,Writing/editing -Current-Up-to-Date Equity, intellectual property, consulting fees-Myolex, Inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Book Royalties from the Concise Guide to Child and Adolescent Psychiatry, 5th Edition-American Psychiatric Association Publishing I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting fee and honorarium-Current-Optos, OIOPSYS, Ellman, and B&L-Only B&L offers a competing product from what will be presented I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Patent and OwnershipTMT Systems -Current-Not related to talk I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Gilead,Consulting Fee-Current-Vertex Pharmaceuticals I/we have no financial relationships to report. Consulting Fee-Current-Allergan, Inc. I/we have no financial relationships to report. Consulting Fee-Current-OPKO, Inc; AbbVie,Consulting Fee-Current-AbbVie I/we have no financial relationships to report. I/we have no financial relationships to report. Travel support to academic meeting-6/2017-Astellas,Consulting Fee-5/2017-Bayer Corporation,Honorarium-5/2017-Making a Difference in Infectious Diseases (Non-profit),Honorarium-current-American Society of Health Systems Pharmacists,Consulting Fee-10/2017-Paratek,Consulting Fee-2/2018-SIGA technologies,Consulting Fee-planned 4/2018-Achaogen,Contracted Research-current-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers honorarium for speaking at a conference for the Pulmonary Hypertension Association-Conference 1/18/16 I/we have no financial relationships to report. grant money paid to institution-current-National Institutes of Health,Consulting Fee-current-Allakos,Consultant, stock/stock options not yet valued-current-BioMarck,Consulting Fee-current-Sanofi-Aventis,Consulting Fee-current-Genentech, Inc.,Consultant, stock/stock options not yet valued-current-Exicure Inc,Consultant, stock/stock options not yet valued-current-Aqualung Therapeutics Corp,Consulting Fee-current-ActoBio Therapeutics,Consulting Fee-current-Lyra Therapeutics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Abbott Vascular,Consulting Fee-Current-W. L. Gore and Associates, Inc.,Contracted Research-Current-Cook Group Incorporated,Consulting Fee-Current-Medtronic, Inc.,Contracted Research-Current-Endologix, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Sunovion, Inc. -Unrelated. I will talk about surgical treatment of tumor related epilepsy. ,Speakers Bureau-Eisai, Inc.-Unrelated. I will talk about surgical treatment of tumor related epilepsy. I/we have no financial relationships to report. Recipient of a 2018 Medtronic Scholarship to attend the HFSA 22nd Annual Scientific Sessions-September 18th, 2018-Medtronic, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Novartis AG,Consulting Fee-Novartis AG,Contracted Research-Celgene,Consulting Fee-Celgene,Contracted Research-Merck and Company, Inc.,Consulting Fee-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Bayer Corporation,Consulting Fee-Current-AstraZeneca,Consulting Fee-Current-Merck and Company, Inc.,Consulting Fee-current-Eli Lilly and Company,Consulting Fee-Current-Roche,Consulting Fee-Current-Bristol-Myers Squibb,Consulting Fee-Current-Celgene,Consulting Fee-Current-Loxo,Consulting Fee-Current-Innate,Consulting Fee-Current-Nanobiotix,Consulting Fee-Current-Eisai, Inc.,Consulting Fee-Current-Aduro,Consulting Fee-Current-Jounce Travel expenses-May 2017-Gilead,Consulting Fee-May 2017-BioTest, AG,Contracted Research-May 2017-Pfizer, Inc.,Contracted Research-December 2017-Ferring Pharmaceuticals,Contracted Research-current-Gilead,Contracted Research-current-Axis Shield,Contracted Research-current-Cheetah Medical,Contracted Research-current-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Abbott Vascular I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-silk road medical Consulting Fee-Current-Actelion,Consulting Fee-Current-Amgen,Consulting Fee-Current-AstraZeneca,Consulting Fee-Current-Bayer Corporation,Consulting Fee-Current-Boehringer Ingelheim Vetmedica GmbH,Consulting Fee-Current-Cardiora,Consulting Fee-Coridea,Consulting Fee-Current-Eisai, Inc.,Consulting Fee-Ionis,Consulting Fee-Ironwood,Consulting Fee-Merck and Company, Inc.,Consulting Fee-MyoKardia,Consulting Fee-Novartis AG,Consulting Fee-Sanofi,Consulting Fee-Tenax,Consulting Fee-Current-United Therapeutics I/we have no financial relationships to report. I/we have no financial relationships to report. Research Grant-Current-Medtronic, Inc.,Research Grant-Current-C2 Therapeutics,Research Grant-Current-CSA Medical,Research Grant-Current-CDx Medical,Consulting Fee-Current-Shire I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-C2 therapeutics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Terumo Cardiovascular Systems Group,Contracted Research-Current-Cook Group Incorporated,Contracted Research-Current-Bard Peripheral Vascular, Inc.,Contracted Research-Current-W. L. Gore and Associates, Inc.,Contracted Research-Current-Medtronic, Inc.,Honorarium-current-Terumo Cardiovascular Systems Group,CEC meetings Honorarium-Current-W. L. Gore and Associates, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Advisory Board-Current-Abbott Vascular,Advisory Board-Current-BioClinica,Advisory Board-Current-Boston Scientific Corporation,Advisory Board-Current-Medtronic, Inc.,Advisory Board-Current-Philips Medical Systems, Inc.,Advisory Board-Current-Spectranetics Corporation,Advisory Board-Current-Shockwave Medical,Advisory Board-Current-Terumo Cardiovascular Systems Group,Advisory Board-Current-Volcano Therapeutics, Inc.,Advisory Board-Current-Lamamed Solutions I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Sera Prognostics,Consulting Fee-current-Vermillion,Consulting Fee-current-Natera,Consulting Fee-current-Allergan,Consulting Fee-current-Lunada,Consulting Fee-current-Counsyl/Myriad,Consulting Fee-ended 1/1/18-Progenity,Consulting Fee-current-Roche,Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-current-Bayer Corporation,Speakers Bureau-AMAG,Consulting Fee-current-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-No relationship I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Abbvie, AnaptysBio, Asana, Arena, Boehringer-Ingelheim, Dermavant, Eli Lilly, Galderma, GlaxoSmithKline, Glenmark, Incyte, Kiniksa, Leo, Menlo, Novartis, Pfizer, Regeneron-Sanofi, Realm ,Speakers Bureau-Current-Regeneron-Sanofi,Contracted Research-Current-Galderma I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Acadia,Consulting Fee-current-Abbvie,Consulting Fee-terminated-Adamas,Consulting Fee-current-Anavex,Consulting Fee-current-Allergan,Consulting Fee-current-Acorda Therapeutics,Consulting Fee-current-Denali,Consulting Fee-current-Neuroderm,Consulting Fee-current-Neurocrine,Consulting Fee-current-Revance,Consulting Fee-current-Sanofi-Aventis-Sanofi,Consulting Fee-current-Sunovion,Consulting Fee-current-TEVA,Consulting Fee-current-Takeda Pharmaceuticals, Inc.,Consulting Fee-current-Voyager,Consulting Fee-current-US World Meds,Contracted Research-current-Biogen Idec,Contracted Research-current-Roche,Contracted Research-current-Neuroderm,Contracted Research-current-Sanofi-Aventis,Contracted Research-current-Sun Pharma,Contracted Research-current-NINDS,Contracted Research-current-Michael J Fox Foundation,Contracted Research-current-Parkinson's Foundation,Consulting Fee-current-Michael J Fox Foundation,Consulting Fee-current-Parkinson's Foundation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Symphogen, Morphosis, AstraZeneca/Medimmune, Pfizer, Merck-None I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Syndax,Consulting Fee-current-Symphogen,Consulting Fee-current-Synaffix I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-SK Lifescience I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Genomic Health, Inc. (GHI),Advisory Board-Genomic Health, Inc, (GHI) I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Abbvie consultant I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-Mesh Suture, Inc. I/we have no financial relationships to report. Consulting Fee-current-Genentech, Inc.,Consulting Fee-current-Bristol-Myers Squibb Sanofi Pharmaceuticals Partnership,Consulting Fee-current-MSD I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Named inventor of QI Advisor and received royalties from MDmetrix. No royalties have been paid to date given the company is relatively new. Also, board member of MDmetrix. Receive small equity component (58,500 ISO).-Current-MDmetrix I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Vertex Pharmaceuticals Inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Pfizer, Inc.,Speakers Bureau-Current-Abbvie,Consulting Fee-Ironwood,Consulting Fee-Abbvie I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. travel reimbursement for non-CME educational event/training-ended 9/9/2017-Stryker I/we have no financial relationships to report. Consulting Fee-current-Olympus Respiratory America/Spiration and Janssen Pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-ended 12/31/18-Nektar Therapeutics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Health2047, Inc not a manufacturer, an IT company I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-Curable Health I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Johnson and Johnson,Training-Current-Intuitive Surgical I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Research Grant-National Institutes of Health,Research Grant-Pacira Pharmaceuticals,Honoraria-Intuitive Surgical Salary-current-Novartis AG,Salary-12/31/2017-Celgene,Travel support-current-Novocure Ltd I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-Kaleo,Speakers Bureau-current-AstraZeneca,Consulting Fee-current-ALK-Abelló,Contracted Research-current-AstraZeneca,Consulting Fee-current-Pfizer, Inc.,Consulting Fee-current-TEVA,Speakers Bureau-current-TEVA,Contracted Research-current-GlaxoSmithKline,Contracted Research-current-Novartis AG,Consulting Fee-current-DBV I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Veryan Medical, LTD,Speakers Bureau-Current-W. L. Gore and Associates, Inc.,Chair, Clinical Events Committee-Current-Bard Peripheral Vascular, Inc. I/we have no financial relationships to report. Contracted Research-Current-Bridge Biotherapeutics; Mission Therapeutics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. CMO-Current-Vivacitas Oncology I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Research Grant-Current-Merck and Company, Inc.,Research Grant-Current-Pfizer, Inc.,Research Grant-current-Sanofi-Pasteur I/we have no financial relationships to report. Consulting Fee-Current-Sanofi-Aventis I/we have no financial relationships to report. Consulting Fee-Ended (7/2018)-UCB I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Alcon-B&L and Alcoy offer competing drugs than what is presented. The others have no correlation.,Consulting Fee-Bausch & Lomb,Consulting Fee-Par Pharmaceuticals,Consulting Fee-Sandoz,Consulting Fee-Watson Laboratories,Consulting Fee-Zeiss Meditech Consulting Fee-Current-Auris Health Consulting Fee-current-Olympus America,Consulting Fee-current-Cook Medical I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Johnson and Johnson-I will talk about my experience and literature review with Femtoseconds lasers I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Scientific Advisory Board-March 2018-Inova Diagnostics Consulting Fee-current-Boston Scientific Corporation,Consulting Fee-current-Cook Group Incorporated I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Sanofi-Aventis,Consulting Fee-current-FIRE1,Consulting Fee-current-cardionomic,Consulting Fee-current-Novartis AG,Consulting Fee-current-Gore,Contracted Research-current-Abbott Vascular,Contracted Research-current-Otsuka America Pharmaceutical, Inc.,Contracted Research-current-Boehringer Ingelheim Vetmedica GmbH,Consulting Fee-current-AstraZeneca,Contracted Research-current-Sequana Medical I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Abbott Vascular,Consulting Fee-Current-Edwards Lifesciences LLC,Consulting Fee-Current-GE Healthcare Bio-Sciences,Spouse employment-Current-Bay Labs,Consulting Fee-Current-Bay Labs I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-current-Biomarin,Contracted Research-current-Bluebird Bio,Contracted Research-current-Celgene,Contracted Research-current-Novartis AG,Contracted Research-current-Pfizer, Inc.,Contracted Research-current-Shire,Consulting Fee-current-Novartis AG,Consulting Fee-current-Celgene,Consulting Fee-bluebird bio I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Boehringer Ingelheim Vetmedica GmbH I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Bristol-Myers Squibb,Consulting Fee-Five Prime Therapeutics,Stock-Five Prime Therapeutics,Spouse, Consulting-Amgen,Spouse, Patent royalties through institution-Bristol-Myers Squibb,Spouse, Stock options-Jounce Therapeutics,Spouse, Consulting-MedImmune / AstraZeneca,Spouse, Consulting-Merck and Company, Inc.,Spouse, Consulting, Stock options, Research grants, Patent royalties through institution-Potenza Therapeutics,Spouse, Consulting, Stock options-Tizona Therapeutics I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Medtronic, Inc.,Royalty-Current-Medtronic, Inc.,Consulting Fee-Current-NuVasive,Consulting Fee-Current-Thompson Surgical, Inc.,Institutional Fellowship Support-Current-AO,Institutioanl Fellowship Support-Current-Globus Medical,Institutional Fellowship Support-Current-NREF I/we have no financial relationships to report. Ownership Interest-Current-Salubris Analytics Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-Current-Google Inc. Contracted Research-current-Merck and Company, Inc.,I review grants for the Gilead Research Scholars Program in HIV and receive financial compensation for doing so.-current-Gilead,Salary-current-Dynamed Plus, EBSCO I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. own stock-current-Merck and Company, Inc. Contracted Research-Current-PUMA Oncology,Contracted Research-Current-Amgen,Contracted Research-Current-Celgene,Contracted Research-Current-Oncotherapy,Contracted Research-Current-Merck and Company, Inc.,Contracted Research-Current-Hitachi,Contracted Research-Current-Angle Inc I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Founder-current-Neuromuscular Dynamica, LLC Receipt of Intellectual Property Rights/Patent Holder-Current-Save My Scope, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-cvs health I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-current-Illumina,Contracted Research-current -shire,Salary-spouse-Centene,investigator initiated research -current -Eli Lilly,conference support-current-bluebird bio ,conference support-current-GSK,Contracted Research-current -IONIS I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Alcon Labs Speakers Bureau-Current-Salix pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Johnson and Johnson,Consulting Fee-Current-Medtronic, Inc.,Speakers Bureau-Current-Bayer Corporation,Consulting Fee-Current-Epix,Consulting Fee-Current-VytronUS Speakers Bureau-Medtronic, Inc.,Speakers Bureau-Biotronik, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-F. Hoffmann La Roche Ltd.,Consulting Fee-Current-Dako I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-6/16/18-Bristol-Myers Squibb,Consulting Fee-4/18/18-Genentech, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Opthotech Inc.,Research Support for Clinical trials-current-Quark,Equity Ownership -current-Opticent Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-May 2018-PLexus I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Sage Therapeutics I/we have no financial relationships to report. I/we have no financial relationships to report. Spouse’s salary -Current-Takeda Pharmaceuticals, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-current-Halyard I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Royalty-Current-Guilford Press,Royalty-Current-Oxford Press,Royalty-Current-Wolters Kluver,Unpaid Member Board of Directors of a non-profit patient support group - Tourette Association of American-Current-Tourette Association of American,Unpaid member of the scientific advisory board of the non-profit Anxiety and Depression Association of American-Current-Anxiety and Depression Association of American,Unpaid member of the scientific advisory board of the non-profit patient support organization Trichotillomania Learning Center-Current-Trichotillomania Learning Center I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-Current-Guardant Health-Genetic based mutational testing for tumor treatment. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Study closed October 2017-Cook Group Incorporated I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Nu Skin I/we have no financial relationships to report. Speakers Bureau-CURRENT-Abbott Laboratories I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Pfizer, Inc.,Consulting Fee-current-Analgesic Solutions,Research Grant-current-Collegium Pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Speakers Bureau-St. Jude Medical, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-Current-AtriCure, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Alcon,Consulting Fee-current-Allergan,Consulting Fee-current-Bausch and Lomb,Consulting Fee-current-Aerie Pharmaceutical,Consulting Fee-current-Eyenovia,non-financial support (research equipment)-current-Zeiss Meditec,non-financial support (research equipment)-current-Optovue,non-financial support (research equipment)-current-Topcon,non-financial support (research equipment)-current-Heidelberg Engineering,non-financial support (research equipment)-other-Centervue,non-financial support (research equipment)-current-Optos,non-financial support (research equipment)-current-Tomey I/we have no financial relationships to report. Chicago Dizziness and Hearing - husband is partner-husband I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Abbott Nutritionals,Consulting Fee-current-Mead Johnson Consulting Fee-AstraZeneca I/we have no financial relationships to report. I/we have no financial relationships to report. Partial salary support through employer-Current-Tricida Consulting Fee-Current-Sage Products LLC I/we have no financial relationships to report. Medical Review Board-Current-Health Navigator Contracted Research-current-celmatix I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. PATENT: MICROTUBULE POLYMERIZATION MODULATORS FOR TREATING LMNA-RELATED DILATED CARDIOMYOPATHY. Serial No.  62/437,170 -Current I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Genentech, Inc.,Scientific Advisory Board-current-Leap,Consulting Fee-current-Eli Lilly and Company,Consulting Fee-current-Carrick Therapeutics,Consulting Fee-current-GlaxoSmithKline,Consulting Fee-current-Seattle Genetics Consulting Fee-Genentech, Inc.,Consulting Fee-ended-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-spouse-Novartis AG,Consulting Fee-Ongoing- Spouse-CVS/Caremark,Advisory Board-Ended, 2017-spouse-Astellas,Data Safety Monitoring Board-Ongoing- spouse-Cellgene,Advisory Board-Ended, February 2018-Janssen,Advisory Board-Ended October 2017-Gilead,Advisory Board-Ended Winter 2018-Bayer,Advisory Board-Ended- March 2018-Merck and Company, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-Current-MEDIQUS Asset Advisors, Inc. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Merck and Company, Inc.,Grant-Current-IRX Therapeutics,Consulting Fee-Current-Regeneron I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-current-Amgen,Contracted Research-current-Abbvie,Consulting Fee-current-Luto,Consulting Fee-current-Merck,Consulting Fee-current-AB Imbev,Contracted Research-current-Eli Lilly I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Siemens AG I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Scientific Advisory Board-current I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Salary-current-Abbott Laboratories I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Research Support, Consultancy, Speaker bureau-AstraZeneca,Research Support, Consultancy-Bayer Corporation,Research Support, Consultancy, Speaker bureau-Pfizer, Inc.,Research Support, Speaker bureau-Tesaro,Contracted Research-Eli Lilly and Company,Contracted Research-Jounce,Research Support, Consultancy-Seattle Genetics,Contracted Research-Kyowa,Contracted Research-Constellation,Consulting Fee-Aduro,Consulting Fee-Almac,Consulting Fee-Atrin,Consulting Fee-Bristol-Myers Squibb,Consulting Fee-Calithera,Consulting Fee-Clovis,Consulting Fee-Cybrexa,Consulting Fee-EMD Serono,Consulting Fee-Ignyta,Consulting Fee-Jansen, Consultancy, Speaker bureau-Merck and Company, Inc.,Research Support, Consultancy-Vertex Pharmaceuticals I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Clinical Trial Principal Investigator-currently-Boehringer Ingelheim Vetmedica GmbH I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Contracted Research-Current-Genentech, Inc.,Contracted Research-Current-Merck and Company, Inc.,Contracted Research-Current-Bristol-Myers Squib Aventis I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-12/16/2017-Med-El Corporation I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Ownership Interest-Current-Medical Board Cases I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-4-04-2019-oxeia biopharma, elminda, biodirection,myomo I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-current-Edwards Lifesciences LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-ended 3/1/2017-Biotronik, Inc.,Speakers Bureau-Current-Boston Scientific Corporation,Investigator NON FINANCIAL AMAZE CLINICAL TRIAL-Current-SENTARA HEART,Speakers Bureau-Jan 2015-Johnson and Johnson,Speakers Bureau-Current-Pfizer, Inc.,Speakers Bureau-Current-Bristol-Myers Squibb I/we have no financial relationships to report. Speakers Bureau-Gilead I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. Consulting Fee-Current-Gerson Lehrman Group, Inc. and Guidepoint Global, LLC I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report. I/we have no financial relationships to report.
No Bio Available.